BE905763A - Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol - Google Patents
Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol Download PDFInfo
- Publication number
- BE905763A BE905763A BE0/217415A BE217415A BE905763A BE 905763 A BE905763 A BE 905763A BE 0/217415 A BE0/217415 A BE 0/217415A BE 217415 A BE217415 A BE 217415A BE 905763 A BE905763 A BE 905763A
- Authority
- BE
- Belgium
- Prior art keywords
- alcohol
- powdering
- extracting
- circulatory disorders
- deer antler
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
Abstract
The use of a prod. extracted fro deer antlers in the pure state, diluted or in admixture, to improve circulatory disorders, is new. The antlers of a young deer, (2-3 branches) are powdered or are extracted with an alcohol or an other solvent.
Description
BOUGARD Marianne et OSTROWSKI Réal
Description:
le produit actif est un extrait de corne de jeune
cerf, généralement à deux ou trois branches. Son nom va de "deer antler" à "cornu cervi" en pasaant par d'autres appel-
-lations suivant tout un chacun et actuellement surtout produit en Chine comme supplément nutritif et parfois exploité chez nous comme tel.
Le principe de notre découverte est son utilisation dans le cadre d' une amélioration ou même d'une guérison
de problèmes circulatoires d'ordre général ( jambes lourdes, varices, cyanoses périphériques, oedèmes des membres inférieurs, ect....) De nombreux essais et de nombreux témoignages attestent que nous avons là, découvert une application
thérapeutique nouvelle et ouvrant de nouveaux horizons
par rapport aux traitements allopathiques classiques.
1 Exemples d' application: - la disparition (chez des dizaines et des dizaines de personnes prêtes à témoigner) de la sensa-
-tion de jambes lourdes après une ou deux semaines de traite- <EMI ID=1.1>
-une guérison remarquable d'un cas de cyanose périphérique conséquent, s'il en est, puisque la couleur des pieds et des jambes de la personne étaient littéralement bleu- noirs.
-des régressions d' oedèmes, de varicosités, de varices. Amélioration de claudication inter-
-mittante, éléphantiasis, artérites diabétiques ou autres.
-il est évident que combinées aux améliorations circulatoires périphériques, nous avons noté des améliorations chez des personnes souffrant <EMI ID=2.1>
verbale. Un cas souffrant de Parkinson s'est révélé très satisfait de pouvoir diminuer san traitement allopathique, et de constater une régression de sa pathologie.
Présentation du produit: La base thérapeutique est donc la corne de jeune cerf, soit réduite en poudre, soit traitée à l' alcool ou par n' importe quel autre extracteur de principe actif quel qu' il soit. Nous utilisons une de ces formes sous une marque déposée.
Ce produit ne représente pas l'invention elle-
même, mais une de ses formes commerciales.
Notons que notre découverte ne s'arrête pas là:
dans les cas qui semblaient légèrement tenaces (surtout les personnes souffrant de troubles veineux (varices, varicosités), en sus des problèmes artériels ou capillaires (plus particu-
-lièrement sensibles au produit que nous déposons en brevet), nous avons pu remédier à cette résistance en additionnant au produit de base, un supplément de gelules d' harpagophytum ce supplément possédant un effet potentialisateur et complé-
-mentaire au traitement de base.
Il est également important de signaler que le principe de base que nous déposons ce jour en brevet peut être mélangé
à d'autres sans être affecté quant à son action circulatoire. Par exemple, nous lui additionnons du ginseng et/ou d'autres plantes en fonction des effets supplémentaires recherchés
(dans le cas du ginseng, il s' agit notamment d'un effet
<EMI ID=3.1>
de 1' utilisation de la corne de cerf dans tout traitement circulatoire et ce, même si le produit se voit traité de quelque manière que ce fût ou additionné à d'autres molécul es. La découverte réside dans SON principe actif à l'état pur, dilué ou en mélange.
BOUGARD Marianne and OSTROWSKI Réal
Description:
the active product is an extract of young horn
deer, usually two or three branches. Its name goes from "deer antler" to "horned cervi" passing by other calls-
-lations according to everyone and currently mainly produced in China as a nutritional supplement and sometimes used here as such.
The principle of our discovery is its use in the context of an improvement or even a cure
general circulatory problems (heavy legs, varicose veins, peripheral cyanosis, edema of the lower limbs, ect ....) Numerous tests and numerous testimonies attest that we have discovered an application there
new therapeutic and opening new horizons
compared to conventional allopathic treatments.
1 Examples of application: - the disappearance (in dozens and dozens of people ready to testify) of the sensa-
-tion of heavy legs after one or two weeks of milking- <EMI ID = 1.1>
- remarkable healing of a case of peripheral cyanosis, if any, since the person's feet and legs were literally blue-black in color.
- regressions of edemas, spider veins, varicose veins. Improved inter-claudication
-mittante, elephantiasis, diabetic arteritis or others.
-it is obvious that combined with peripheral circulatory improvements, we noted improvements in people suffering from <EMI ID = 2.1>
verbal. A case suffering from Parkinson's was very satisfied to be able to reduce his allopathic treatment, and to observe a regression in his pathology.
Presentation of the product: The therapeutic base is therefore the horn of a young deer, either reduced to powder, or treated with alcohol or with any other extractor of active principle whatsoever. We use one of these forms under a registered trademark.
This product does not represent the invention itself
same, but one of its commercial forms.
Note that our discovery does not stop there:
in cases that seemed slightly stubborn (especially people with venous disorders (varicose veins, spider veins), in addition to arterial or hair problems (more particularly
- fully sensitive to the product we are patenting), we were able to remedy this resistance by adding to the basic product, a supplement of harpagophytum capsules, this supplement having a potentiating and complete effect.
-mental to basic treatment.
It is also important to note that the basic principle that we are filing today for a patent can be mixed
to others without being affected as to its circulatory action. For example, we add ginseng and / or other plants to it depending on the additional effects sought
(in the case of ginseng, this is notably an effect
<EMI ID = 3.1>
the use of deer horn in all circulatory treatment, even if the product is treated in any way whatsoever or added to other molecules. The discovery lies in HIS active ingredient in its pure state, diluted or mixed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE0/217415A BE905763A (en) | 1986-11-17 | 1986-11-17 | Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE905763 | 1986-11-17 | ||
BE0/217415A BE905763A (en) | 1986-11-17 | 1986-11-17 | Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol |
Publications (1)
Publication Number | Publication Date |
---|---|
BE905763A true BE905763A (en) | 1987-03-16 |
Family
ID=25655113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/217415A BE905763A (en) | 1986-11-17 | 1986-11-17 | Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE905763A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002091857A1 (en) * | 2001-05-17 | 2002-11-21 | Cyclogen Co., Ltd | Health food and method for preparation thereof |
WO2004112806A1 (en) * | 2003-06-26 | 2004-12-29 | Canada Changmin Nutraceutique Co. Ltd | Composition for treating or preventing neural disorders |
-
1986
- 1986-11-17 BE BE0/217415A patent/BE905763A/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002091857A1 (en) * | 2001-05-17 | 2002-11-21 | Cyclogen Co., Ltd | Health food and method for preparation thereof |
WO2004112806A1 (en) * | 2003-06-26 | 2004-12-29 | Canada Changmin Nutraceutique Co. Ltd | Composition for treating or preventing neural disorders |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ríos | Essential oils: What they are and how the terms are used and defined | |
Tucker | Frankincense and myrrh | |
US7576049B2 (en) | Solvent based plant extracts | |
Wills et al. | Herbal products: active constituents, modes of action and quality control | |
BR112019014463A2 (en) | EXTRACTION AND STABILIZATION OF PHYTO CANABINOIDS AND TERPENS ON THE BASIS OF LIPIDE ASSISTED BY ENZYME AND PRODUCTS OBTAINED | |
Tamrat et al. | Anti-inflammatory and analgesic activities of solvent fractions of the leaves of Moringa stenopetala Bak.(Moringaceae) in mice models | |
Fiume et al. | Safety assessment of Rosmarinus officinalis (rosemary)-derived ingredients as used in cosmetics | |
Drewes et al. | Hypoxis hemerocallidea—not merely a cure for benign prostate hyperplasia | |
WO1998005299A1 (en) | Novel cosmetic compositions for beautifying and lightening skin | |
Mechqoq et al. | Ethnobotany, phytochemistry and biological properties of Argan tree (Argania spinosa (L.) Skeels)(Sapotaceae)-A review | |
Yeshi et al. | Essential oils and their bioactive molecules in healthcare | |
CA2074485A1 (en) | Cosmetic preparation containing a sunflower (helianthus annuus) seed meal extract | |
Skaria | Aromatic plants | |
JP5856955B2 (en) | Emulsified cosmetics using fish-derived cholesterol | |
Roy et al. | Evaluation of phytoconstituents and assessment of adaptogenic activity in vivo in various extracts of Rhododendron arboreum (leaves) | |
Öztürk et al. | Hepatoprotective activity of Hypericum perforatum L. alcoholic extract in rodents | |
WO2019086602A1 (en) | Particular extract from perfume plants, aromatic plants and medicinal plants, method for obtaining said extract, compositions containing same and uses thereof | |
BE905763A (en) | Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol | |
Nyalo et al. | Quantitative phytochemical profile and in vitro antioxidant properties of ethyl acetate extracts of xerophyta spekei (baker) and grewia tembensis (fresen) | |
EP3917554B1 (en) | Method for obtaining an extract of patchouli leaves and cosmetic uses thereof | |
JP2000073057A (en) | Water soluble antioxidant and production thereof | |
FR2559390A1 (en) | Skin regeneration agents | |
Noumi et al. | Particle size effects on antioxydant and hepatoprotective potential of essential oil from eucalyptus camaldulensis leaves against carbon tetrachloride-induced hepatotoxicity in rats | |
Saloufou et al. | Identification de deux phytostérols biologiquement actifs de l’extrait cyclohexanique des feuilles de Ficus sur (Moraceae) | |
Lin et al. | Sapindus mukorossi seed oil changes tyrosinase activity of α-MSH-induced B16F10 cells via the antimelanogenesic effect of eicosenoic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: BOUGARD MARIANNE Effective date: 19901130 Owner name: OSTROWSKI REAL Effective date: 19901130 |